PayPal is one of 99 limited partners to have committed to the debut fund for the black entrepreneur-focused venture capital firm.
Month: June 2021
Daily Deal Round Up: June 1, 2021
Oriola sold part of its stake in telehealth platform developer Doktor.se through a $61.1m round while bicycle marketplace The Pro’s Closet bagged $40m.
Rising Stars Q&A – Wade Sheffer, GM Ventures
Q&A with Wade Sheffer, managing director, GM Ventures
Wefox locks up $650m in funding
Existing backers Creditease and Salesforce Ventures contributed to a round led by Target Global that valued the online insurance provider at $3bn.
Circle rounds up $440m in funding
FTX was among the backers in the Baidu, Bitmain, CreditEase and Wanxiang-backed virtual currency platform’s latest round as it reportedly prepares for a reverse merger.
Sennder wraps up $240m series D round
The logistics platform developer has collected an extra $80m at a valuation above $1bn to round off a series D round featuring Scania.
Delhivery gets $277m series H shipment
Fidelity has led the SoftBank, Fosun and Bennett Coleman & Co-backed logistics service provider’s latest round, set to precede an IPO slated for 2022.
Tata Digital buys up majority of BigBasket
The online household items and fresh produce marketplace has sealed a $1.2bn majority acquisition by the Tata unit, enabling Alibaba to exit.
Corvus carries series C up to $115m
The Telstra-backed provider of commercial insurance and broker software has reached $162m of total funding through its latest round.
Sprinklr signals IPO plans
Intel Capital looks set exit the marketing technology provider, which has filed to raise up to $100m on the New York Stock Exchange.
Ada Health adds $90m
The health assessment software provider secured the funding in a series B round led by Bayer that also featured Samsung Catalyst Fund.
Xunce Technology zooms to $110m series C
Tencent and Taikang Insurance Group co-led the asset data software producer’s latest round with Citic Private Equity Funds Management.
Binx links to $104m in series E round
Johnson & Johnson’s investment arm has returned to back the molecular diagnostic technology developer, which also counts Novartis, Consort Medical and Wondfo Biotech as investors.